Afluria Quad
Details for Afluria Quad vaccine and its components.
Sponsor:
Seqirus
Administration route:
Intramuscular injection, Subcutaneous injection
Vaccine group:
All people aged ≥5 years
Registered for use in people aged ≥18 years.
Quadrivalent inactivated influenza vaccine
Each 0.5 mL monodose pre-filled syringe contains:
- 15 µg haemagglutinin of each of the 4 recommended influenza virus strains
- <1 µg ovalbumin
May contain traces of:
- sodium taurodeoxycholate
- neomycin
- polymyxin B
- propiolactone
For full details, refer to the product information and consumer medicine information sheets for Afluria Quad vaccine available on the TGA website.
Page history
Last updated:
4 June 2018
Last reviewed:
4 June 2018
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/afluria-quad.